Legacy Pharmaceutical Packaging, LLC has issued a nationwide recall of a blood pressure medication according to the Food and Drug Administration.
The pharmaceutical company is recalling Losartan Tablets USP 25mg, 50mg, and 100mg after a trace amount of a contaminant was found. NMBA is the name of what is being called "a potential human carcinogen," meaning long-term exposure could increase the potential for cancer.
Losartan is a prescription medication used for high blood pressure and congestive heart failure and comes in packages of 30 count bottles, according to the FDA.
For more information on the recall, click here.
- Blood pressure medication recalled after dangerous contamination
- Blood pressure medication recall expands again to include losartan
- Kroger supplier recalls ground beef over plastic contamination concerns
- Certain Goldfish crackers recalled for possible salmonella contamination
- Baby cough syrup is recalled after bacterial contamination
- George H.W. Bush hospitalized for low blood pressure and fatigue
- Half of US adults have high blood pressure in new guidelines
- FDA official says ongoing blood pressure drug investigation will probably uncover more tainted pills
- Honda to recall around 1M vehicles with dangerous air bags
- FDA warns of Salmonella contamination in melons